Effect of long-term treatment with sulfatide on hyperlipidemia and progression of atherosclerosis in WHHL rabbits.
Changes in serum lipids and lipoproteins and progression of atherosclerosis with age were examined in Watanabe heritable hyperlipidemic (WHHL) rabbits with or without treatment with sulfatide. The injection of sulfatide solution caused a reduction of serum triacylglycerols for five months including the period of treatment, but afterwards, failed to lower the level of total cholesterol, triacylglycerols and phospholipids, and to suppress the progression of atherosclerosis. Concentrations of LDL as a major serum lipoprotein in WHHL rabbits with or without the treatment with sulfatide were found to be about 64-fold those of normal rabbits by immunological assay using anti-LDL antiserum, whereas the contents of total cholesterol, triacylglycerols, and phospholipids in WHHL rabbit sera were found to be about 10-fold those of normal rabbits. All WHHL rabbits with or without the treatment with sulfatide contained very small amounts of HDL. Types of apoproteins of isolated LDL and VLDL fractions suggested that the former seemed to be derived from VLDL remnant, and the latter to be derived from chylomicron remnant. It was noted that all WHHL rabbit sera had a significant increased amount of lysophosphatidylcholine, and that the fatty acid composition of total serum lipids had almost no change except for slight decrease in arachidonic acid with age. Pathological examination showed that severe atherosclerotic lesions were not so different between WHHL rabbits with or without treatment with sulfatide at age over 22 months.
Taketomi
T
T
Department of Lipid Biochemistry, Shinshu University School of Medicine, Matsumoto, Japan.
Hara
A
A
Uemura
K
K
Kyogashima
N
N
D000375:Aging / Q000097:blood; D000818:Animals; D001011:Aorta / Q000473:pathology; D001161:Arteriosclerosis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D001835:Body Weight; D002784:Cholesterol / Q000097:blood; D006949:Hyperlipidemias / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D008074:Lipoproteins / Q000097:blood; D011817:Rabbits; D013433:Sulfoglycosphingolipids / Q000627:therapeutic use*
D008074:Lipoproteins; D013433:Sulfoglycosphingolipids; D002784:Cholesterol